Page 473 - Book Hosokawa Nanoparticle Technology Handbook
P. 473

APPLICATIONS                                             6 DESIGN OF NANOPARTICLES FOR ORAL DELIVERY OF PEPTIDE DRUGS








                                                     References  Kisel et al. [47]  Takeuchi et al. [12]  Zhang et al. [15]  Takeuchi et al. [18]  Iwanaga et al. [17]  Li et al. [48]  Damge et al. [19]  Mesiha et al. [49]  Das and Lin [20]  Donini et al. [22]  Lugo et al. [26]  Foss et al. [50] Ichikawa et al. [28, 29]  Sakuma et al. [30]  Kawashima et al. [32]  Kawashima et al. [33]  Carino et al. [31]  Y oo and Park [34]  Attivi et al. [35]











                                                     Peptide drug  Porcine insulin  Elcatonin  Insulin  Elcatonin  Bovine insulin  rhEGF  Procine insulin  Human insulin  Dalargin  Bovine insulin  Salmon calcitonin  Bovine insulin  Vancomycin, bovine   insulin  Salmon calcitonin  TRH  Elcatonin  Insulin  Salmon calcitonin  Human insulin











                                                     Surface-modifying agents  or additives  None  Chitosan  WGA, TL, or UEA1-N-  Glut-PE conjugates  Chitosan or Carbopol Cetyl-mucin, DSPE-PEG  None  Miglyol core  Pluronic acid Tween-80 and PEG20000  Pluronic F68  None  Trehalose  None  None  None Chitosan, poly(acrylic acid)  FAO/Fe3O4  None  Polycationic polymer   (Eudragit RS)
















                                               Characteristics of representative nanoparticulate carriers for oral peptide delivery.
                                                     Particle size  50–250 nm  470, 660, 4100 nm  190 nm  N/A  348, 453, 479 nm  306 nm  220 nm  85 nm  100 nm  300 nm  200–1200 nm  230–340 nm  170–350 nm  400–1250 nm  250 nm  240 nm  1  m (80%)     171–315 nm  350 nm











                                                     Preparation method  Thin-layer hydration/  ultrasonication  Thin-layer hydration/  ultrasonication  Reverse evaporation  Thin-layer hydration  Thin-layer hydration  Thin-layer hydration  Interfacial emulsion   polymerization In situ ionic polymerization  Ionic polymerization Dispersion polymerization Dispersion polymerization Dispersion polymerization Dispersion polymerization  Dispersion polymerization  Emulsion-solvent diffusion Emulsion-solvent diffusion  Phase inversion  Solvent diffusion  Multiple emulsion   evaporation















                                                     Carrier type and base materials  Phosphatidylethanol based lipids  DPPC/DCP or SA  DPPC/Chol/DOPE-PEG  Poly(alkyl(meth)acrylates)  P(NIPAAm)/P(MAA-g-EG)  P(St)/hydrophilic polymer chains  Polyesters/polyanhydrides











                                            Table 6.1      Liposomes  DSPC/DCP/Chol  Soyalecithin/Chol  DPPC/Chol/SA  P(IBCN)  P(IBCN)  P(IBCN)  P(MAA-g-EG)  P(MAA-g-EG)  P(AA-g-EG)  PLGA  PLGA  PLGA  PLGA  PCL








              446
   468   469   470   471   472   473   474   475   476   477   478